Indefinite Delivery Contract SPE2DR25D9139

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $499,999,999 contract, valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This supports the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide.

The original solicitation was issued by the DLA Troop Support Medical Supply Chain to establish Pharmaceutical Prime Vendor Global Program Generation V contracts for worldwide pharmaceutical support to various DoD customers. The estimated $30.3 billion program will result in multiple regional awards, with at least three different contractors selected, to ensure resiliency and access to vital pharmaceuticals during contingencies or natural disasters. The contracts will have a 30-month base period and three 30-month option periods, and will be awarded on a lowest price technically acceptable basis, potentially utilizing reverse auctions to determine final distribution fees.